Interpace Biosciences Inc
OTC:IDXG
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IDXG's stock price target?
Not Available
IDXG doesn't have any price targets made by Wall Street professionals.
What is Interpace Biosciences Inc's Revenue forecast?
Projected CAGR
41%
For the last 8 years the compound annual growth rate for Interpace Biosciences Inc's revenue is 46%. The projected CAGR for the next 1 year is 41%.